2021-06-25
优替德隆是通过基因工程合成的埃博霉素类似物。
2020
news
-
-
2021-06-22组合生物合成关键技术平台
-
2021-06-22研发模式与关键技术
-
2021-06-22Combinatorial Biosynthesis Technology
-
2021-06-22VisionTo become a leading pharmaceutical company developing differentiated products. -
2021-06-22MissionCommitted to developing innovative drugs to benefit cancer patients -
2023-08-08Microbial Fermentation Production PlatformBased on the microbial fermentation production platform, we design the fermentation process, including the configuration of media and the research of COAs, to successfully realize the transformation of target compounds from the pilot stage to large-scale production. -
2022-04-25Simon Guan, PhDOver 10 years of experience in portfolio management, business development and alliance management of innovative oncology products. Simon is currently responsible for operation related work at Biostar including project management, business development, public relations, et al. -
2023-08-08Microbial Drug Formulation Development PlatformsBased on the microbial drug formulation development platforms, we solve the bottleneck of microbial drug formulation, develop a variety of microbial drug dosage forms, and further improve the product efficacy and safety, as well as enhance patient compliance. -
2021-06-28发酵工程师本科及以上
-
2021-06-25Cheng ZhangMore than 20 years of experience in production, site operation and management, as well as quality control. In charge of manufacturing and quality control at Biostar since 2015. -
2021-06-28纯化工程师本科及以上
